MarketPeel
Insider Trading Intelligence
Pricing
…
HF

Henry A. Fernandez

RPRX
DIRECTOR · ROYALTY PHARMA PLC · CIK 0001416750
FILING MIX · LIFETIME89%/11%
BUYS
92
SELLS
11
TOTAL VALUE
$113.85M
COMPANIES
2
ACTIVE SINCE
Aug 2020
HOLDINGS NOW
1,797,285
AVG SELL PX
$571.45
TRADE KIND
SHOWING 103 / 103
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
45 backtested trades · 8 horizons · 66 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Henry A. Fernandez, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d45+97.78%+2.13%-0.46%+2.59%+2.96%7.60
14d45+86.67%+3.53%-0.26%+3.79%+6.32%8.00
30d45+84.44%+5.14%+0.80%+4.34%+6.42%6.99
60d45+84.44%+5.04%+2.32%+2.72%+5.06%3.43
90d45+73.33%+5.21%+2.32%+2.89%+5.83%3.04
180d45(4 pending)+90.24%+16.11%+10.11%+2.97%+0.73%—
1y45(28 pending)+52.94%+4.10%+11.44%-7.34%+4.50%—
2y45(34 pending)+81.82%+19.20%+38.32%-19.12%-16.00%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RPRX · 65,324 shares · as of Jun 30, 2025
016,33132,66248,99365,32420212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 92 buys / 11 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
80$565.17$45.2K1,731,961May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,122$562.47$631.1K1,730,681May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
800$563.39$450.7K1,731,481May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
120$559.40$67.1K1,728,081May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
400$564.42$225.8K1,731,881May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
240$560.28$134.5K1,728,321May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,238$561.56$695.2K1,729,559May 15, 2026May 18, 2026 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
75,707——0Apr 28, 2026Apr 30, 2026 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Gift
75,707——410,776Apr 28, 2026Apr 30, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
200$520.00$104.0K1,493,847Feb 17, 2026Feb 17, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
240$517.32$124.2K1,493,287Feb 17, 2026Feb 17, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
360$519.45$187.0K1,493,647Feb 17, 2026Feb 17, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
6,000$524.18$3.15M1,493,047Feb 13, 2026Feb 17, 2026 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
42,193——42,193Jan 26, 2026Jan 28, 2026 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
3,190$535.51$1.71M1,482,554Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
114$539.35$61.5K334,789Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,106$539.57$596.8K1,486,487Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
480$540.46$259.4K1,486,967Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
140$532.37$74.5K332,919Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
552$536.02$295.9K334,278Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
260$533.22$138.6K333,179Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
80$541.23$43.3K1,487,047Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
317$536.90$170.2K334,595Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
360$531.98$191.5K1,477,197Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
80$537.75$43.0K334,675Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,892$536.34$1.01M1,484,446Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,124$533.12$599.2K1,478,321Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
40$541.90$21.7K335,069Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
504$538.77$271.5K1,485,381Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
547$535.10$292.7K333,726Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,043$534.55$557.5K1,479,364Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
431$537.31$231.6K1,484,877Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
240$540.37$129.7K335,029Dec 5, 2025Dec 9, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
18$547.49$9.9K1,279,908Jul 25, 2025Jul 28, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
43$550.41$23.7K1,279,951Jul 25, 2025Jul 28, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
23$546.40$12.6K1,279,890Jul 25, 2025Jul 28, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
2,400$535.11$1.28M332,779Jul 24, 2025Jul 28, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
9,916$544.70$5.40M1,279,867Jul 24, 2025Jul 28, 2025 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,064$35.24$37.5K65,324Jun 30, 2025Jun 30, 2025 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
7,614——64,260May 13, 2025May 14, 2025 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,141$32.87$37.5K56,646Mar 31, 2025Apr 1, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
4,700$574.98$2.70M1,269,851Feb 24, 2025Feb 25, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
100$575.66$57.6K1,269,951Feb 24, 2025Feb 25, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
500$569.86$284.9K1,265,151Feb 24, 2025Feb 25, 2025 ↗View →
MSCI
MSCI INC.
SALE
Chairman and CEO
32,279$587.48$18.96M1,264,651Feb 6, 2025Feb 10, 2025 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
58,370——1,296,930Feb 6, 2025Feb 10, 2025 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
36,846——36,846Jan 31, 2025Feb 4, 2025 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
40,780——40,780Jan 31, 2025Feb 4, 2025 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
44,920——44,920Jan 31, 2025Feb 4, 2025 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
29,564——29,564Jan 27, 2025Jan 29, 2025 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,503$24.94$37.5K55,505Dec 31, 2024Jan 2, 2025 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,807$613.38$1.11M329,886Dec 5, 2024Dec 9, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
600$610.00$366.0K328,079Dec 5, 2024Dec 9, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
493$614.08$302.7K330,379Dec 5, 2024Dec 9, 2024 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,342$27.92$37.5K54,002Sep 30, 2024Sep 30, 2024 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,399$26.80$37.5K52,660Jun 28, 2024Jun 28, 2024 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
9,293——51,261Jun 7, 2024Jun 10, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
906$460.69$417.4K315,885Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
4,294$468.52$2.01M325,835Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
988$467.24$461.6K321,541Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
863$462.96$399.5K318,193Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
7,500——1,752,767Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
7,500——1,760,267Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
7,500——1,745,267Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,644$469.66$772.1K327,479Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
760$465.74$354.0K320,553Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,600$464.55$743.3K319,793Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
500$459.48$229.7K314,979Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Gift
7,500——15,400Apr 25, 2024Apr 26, 2024 ↗View →
MSCI
MSCI INC.
PURCHASE
Chairman and CEO
1,445$461.92$667.5K317,330Apr 25, 2024Apr 26, 2024 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,240$30.23$37.5K41,968Mar 28, 2024Apr 2, 2024 ↗View →
MSCI
MSCI INC.
SALE
Chairman and CEO
4,036$583.39$2.35M1,516,224Feb 5, 2024Feb 7, 2024 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
7,298——1,520,260Feb 5, 2024Feb 7, 2024 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
84,022——1,559,427Feb 5, 2024Feb 7, 2024 ↗View →
MSCI
MSCI INC.
SALE
Chairman and CEO
46,465$583.39$27.11M1,512,962Feb 5, 2024Feb 7, 2024 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,353$27.71$37.5K40,728Dec 29, 2023Dec 29, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,384$27.08$37.5K39,375Sep 29, 2023Oct 3, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,208$31.03$37.5K37,991Jun 30, 2023Jun 30, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
7,747——36,783Jun 23, 2023Jun 26, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
1,049$35.73$37.5K29,036Mar 31, 2023Mar 31, 2023 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
28,472——1,239,585Feb 8, 2023Feb 10, 2023 ↗View →
MSCI
MSCI INC.
SALE
Chairman and CEO
15,746$556.90$8.77M1,223,839Feb 8, 2023Feb 10, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
943$39.76$37.5K27,987Dec 30, 2022Jan 3, 2023 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
913$41.06$37.5K27,044Sep 30, 2022Sep 30, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
903$41.52$37.5K26,131Jun 30, 2022Jun 30, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
6,328——25,228Jun 24, 2022Jun 24, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
964$38.87$37.5K18,900Mar 31, 2022Apr 1, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASE
32,500$37.49$1.22M58,200Feb 24, 2022Feb 25, 2022 ↗View →
MSCI
MSCI INC.
SALE
Chairman and CEO
42,460$550.45$23.37M1,211,113Feb 7, 2022Feb 9, 2022 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Stock grant
80,187——1,253,573Feb 7, 2022Feb 9, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
958$39.11$37.5K17,936Dec 31, 2021Jan 3, 2022 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
4,275——1,683,665Dec 21, 2021Feb 9, 2022 ↗View →
MSCI
MSCI INC.
SALEGRANT
Gift
7,170——1,676,495Dec 21, 2021Feb 9, 2022 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Gift
4,275——7,900Dec 21, 2021Feb 9, 2022 ↗View →
MSCI
MSCI INC.
PURCHASEGRANT
Gift
7,170——7,900Dec 21, 2021Feb 9, 2022 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
992$37.80$37.5K16,978Sep 30, 2021Sep 30, 2021 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
871$43.04$37.5K15,986Jun 30, 2021Jun 30, 2021 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
5,726——15,115Jun 25, 2021Jun 29, 2021 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
816$45.90$37.5K9,529Mar 31, 2021Apr 2, 2021 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASE
25,700$46.83$1.20M25,700Feb 25, 2021Feb 26, 2021 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
820$45.69$37.5K8,713Dec 31, 2020Jan 4, 2020 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
613$41.17$25.2K7,893Sep 30, 2020Oct 2, 2020 ↗View →
RPRX
ROYALTY PHARMA PLC
PURCHASEGRANT
Stock grant
7,280——7,280Aug 13, 2020Aug 17, 2020 ↗View →
Other insiders · RPRX
Loading peer insiders…
About this filer
CIK 0001416750
ROLE
Director
PRIMARY
RPRX
COMPANIES
2
ACTIVE SINCE
Aug 2020
MARKETPEEL · /INSIDER/0001416750DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback